Quantum-Si

Quantum-Si And Nvidia Are Building?New Drug Discovery Technology Quantum-Si (NASDAQ: QSI) and NVIDIA (NASDAQ: NVDA) have launched a new partnership to advance the development of Quantum-Si’s new proprietary proteomics platform known as Proteus. Proteus is capable of analyzing proteins in extreme detail and can rapidly process highly complex samples. What's happening, the big idea, and more: https://lnkd.in/evMKfiPS Featured | cc: Jeff Hawkins, Todd C. Bennett, Jeff Keyes, Christian LaPointe, PhD, Todd Rearick, Lindsay Thompson, SHRM-CP, John Vieceli, Paula Dowdy, Katherine Atkinson, Jonathan Rothberg, Joe Benson, Steve Sackett, Karen Smith, Doug Farrell, Dennis Nelson, Christopher Bayers, Meredith L. Carpenter, PhD #biotech #ai #artificialintelligence #innovation

Quantum-Si, the protein sequencing company, and SkyWater Technology are to expand their relationship to support the development of Proteus, Quantum-Si’s next-generation platform designed to transform proteomic research. Read more here: https://lnkd.in/ek7Zkhzw #manufacturing #engineering #electricity

Big News from Quantum-Si’s Investor & Analyst Day! Yesterday, Jeff Hawkins, CEO, unveiled some game-changing advancements in protein sequencing and proteomics: Platinum? Pro – Launching in H1 2025, this next-generation platform will streamline workflows, enable custom application development, and provide faster data processing, locally or via the cloud. Proteus? – Coming in H2 2026, this groundbreaking proteomics platform is designed for unprecedented output per sample, rapid sequencing, and automation. We’re also excited to announce new partnerships with industry leaders like VWR, part of Avantor, NVIDIA AI, SkyWater Technology, and Planet Innovation to accelerate innovation and delivery. Catch the full event replay here: https://lnkd.in/enuQsM8J You can read the full recap PR here: https://lnkd.in/eRP3CKPM #Proteomics #Innovation #proteinsequencing #NGPS #QSI #Platinum #PlatinumPro

John Vieceli quoted in GenomeWeb regarding new partnership with NVIDIA AI. https://lnkd.in/er3hZSPV

Our 2025 agreement with Avantor? (NYSE: AVTR), a global leader in life sciences and advanced technology products will bring Quantum-Si’s Next-Generation Protein Sequencing??(NGPS) technology to more researchers and laboratories across the U.S. and Canadian markets in 2025. Our goal is simple...to make it even easier for scientists to access our pioneering #NGPS platform. Stay tuned for more updates from Jeff Hawkins, Todd C. Bennett and the entire #QSI team on how together we will shape the future of science! Press release can be found here: https://bit.ly/3OhmpY9

We’re excited to announce our new partnership with Avantor? (NYSE: AVTR), a global leader in life sciences and advanced technology products. This distribution agreement will bring Quantum-Si’s Next-Generation Protein Sequencing??(NGPS) technology to more researchers and laboratories across the U.S. and Canadian markets in 2025. With Avantor’s extensive reach and expertise, we’re making it easier than ever for scientists to access our pioneering platform, designed to deliver groundbreaking insights into protein structure and function. From drug discovery to biomarker identification, antibody characterization, and beyond, our technology empowers researchers to explore proteomics like never before. Together, Quantum-Si and Avantor are driving advancements in #proteomics research and transforming how scientists approach protein analysis. Stay tuned for more updates on how this collaboration is shaping the future of science! To learn more about agreement visit: https://lnkd.in/eANhw_dY #Proteomics #NextGenerationProteinSequencing #Innovation #NGPS #LifeSciences #Partnerships #QuantumSi

Quantum-Si is excited to announce a collaboration with NVIDIA AI to develop Proteus?, our cutting-edge proteomics platform, and enhance our core technologies of amino acid binders and aminopeptidases. By leveraging NVIDIA’s AI and accelerated computing, we’re driving advancements in data processing to handle the massive data generated by single-molecule protein sequencing. This partnership is set to empower researchers with faster insights into the proteome, fueling breakthroughs in drug discovery, healthcare AI, and beyond. As we continue to push the boundaries of proteomics, this collaboration marks a significant step toward a future where protein sequencing is faster, more accessible, and transformative. Read more here: https://lnkd.in/ePKs_A3t #Proteomics #AI #Innovation #Collaboration #NextGenerationProteinSequencing

We’re thrilled to deepen our collaboration with SkyWater Technology to accelerate the development of #Proteus?, Quantum-Si’s next-generation proteomics platform. Building on the success of our first-generation Platinum? platform, this partnership combines #QSI's biotechnology expertise with SkyWater’s advanced manufacturing capabilities. The expanded collaboration will develop the consumable for Proteus that will enable simultaneous large factor, protein sequencing with unparalleled accuracy. Together, we’re driving innovation to deliver a platform that offers unmatched precision, flexibility, and automation—empowering groundbreaking discoveries in biomarkers and disease treatments. This expanded collaboration represents a key step in revolutionizing #proteomics and advancing the future of life sciences. Learn more: https://bit.ly/4hQkJm9 #Innovation #LifeSciences #Collaboration

We’re excited to announce our expanded partnership with Planet Innovation to develop and manufacture Proteus?, Quantum-Si’s next-generation proteomics platform. With Planet Innovation’s proven expertise in designing and producing world-class life science instruments, this collaboration aims to bring Proteus? to market in under two years. Already the manufacturing partner for our upcoming Platinum? Pro instrument, the next instrument in our portfolio, Planet Innovation’s deep experience ensures a seamless transition from development to commercialization. Together, we’re working to make #proteomics more accessible and impactful for researchers, scientists, and clinicians worldwide. Stay tuned as we advance toward the future of proteomics! Learn more: https://lnkd.in/eS5HyfwK #Proteomics #Innovation #LifeSciences #Collaboration #NextGenTech

Today is the day for #ELRIG - Protein Sciences in Drug Discovery event. Check out Quantum-Si's team in Booth 14 today and tomorrow. Paru Oatey and Richard Broadhead are here to connect with innovators in protein science and drug discovery, sharing insights into how our Next-Generation Protein Sequencing? technology is transforming research. Don’t miss the chance to discuss how #QSI is empowering scientists to drive discoveries faster and more efficiently. If you can't make it, no worries, connect with us here: #ProteinScience #DrugDiscovery